Edition:
United States

NanoVibronix Inc (NAOV.OQ)

NAOV.OQ on NASDAQ Stock Exchange Capital Market

4.47USD
13 Dec 2017
Change (% chg)

$-0.02 (-0.45%)
Prev Close
$4.49
Open
$4.59
Day's High
$4.59
Day's Low
$4.43
Volume
21,868
Avg. Vol
--
52-wk High
$4.89
52-wk Low
$3.68

Chart for

About

NanoVibronix, Inc. is a medical device company focusing on noninvasive biological response-activating devices that target wound healing and pain therapy. The Company's products include PainShield, WoundShield and UroShield. Its products under development include Renooskin and Endotrachshield. The Company's principal research and... (more)
No analyst recommendations are available for .

Overall

Beta: --
Market Cap(Mil.): $19.27
Shares Outstanding(Mil.): 2.63
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.16 16.44
EPS (TTM): -- -- --
ROI: -- 14.01 10.62
ROE: -- 16.85 14.20

BRIEF-Nanovibronix Announces Exclusive U.K. Distributor For Painshield

* NANOVIBRONIX ANNOUNCES EXCLUSIVE UK DISTRIBUTOR FOR PAINSHIELD(TM) PROVIDING PATIENTS AN ALTERNATIVE TO OPIOIDS AND SURGERY

Dec 05 2017

BRIEF-Nanovibronix ‍Expects To Complete Trial For Use Of Painshield In Patients With Trigeminal Neuralgia In Q1 Of 2018​

* NANOVIBRONIX REPORTS SUCCESSFUL INTERIM TRIAL RESULTS FOR USE OF PAINSHIELD(TM) IN PATIENTS WITH TRIGEMINAL NEURALGIA; REPRESENTS POTENTIAL ALTERNATIVE TO OPIOID AND SURGICAL INTERVENTIONS

Nov 29 2017

Earnings vs. Estimates